Circulating miR-192 in liver fluke-associated cholangiocarcinoma patients: a prospective prognostic indicator

Sriamporn, 2004, Prevalence of Opisthorchis viverrini infection and incidence of cholangiocarcinoma in Khon Kaen, Northeast Thailand, Trop Med Int Health, 9, 588, 10.1111/j.1365-3156.2004.01234.x

Chamadol, 2014, Histological confirmation of periductal fibrosis from ultrasound diagnosis in cholangiocarcinoma patients, J Hepatobiliary Pancreat Sci, 21, 316, 10.1002/jhbp.64

Khan, 2007, Cholangiocarcinoma and its management, Gut, 56, 1755, 10.1136/gut.2007.138859

Wongkham, 2012, State of serum markers for detection of cholangiocarcinoma, Asian Pac J Cancer Prev, 13, 17

Levy, 2005, The value of serum CA 19-9 in predicting cholangiocarcinomas in patients with primary sclerosing cholangitis, Dig Dis Sci, 50, 1734, 10.1007/s10620-005-2927-8

Bamrungphon, 2007, A new mucin antibody/enzyme-linked lectin-sandwich assay of serum MUC5AC mucin for the diagnosis of cholangiocarcinoma, Cancer Lett, 247, 301, 10.1016/j.canlet.2006.05.007

Silsirivanit, 2011, A novel serum carbohydrate marker on mucin 5AC: values for diagnostic and prognostic indicators for cholangiocarcinoma, Cancer, 117, 3393, 10.1002/cncr.25912

Bartel, 2004, MicroRNAs: genomics, biogenesis, mechanism, and function, Cell, 116, 281, 10.1016/S0092-8674(04)00045-5

Lee, 2009, MicroRNAs in cancer, Annu Rev Pathol, 4, 199, 10.1146/annurev.pathol.4.110807.092222

Garzon, 2009, MicroRNAs in cancer, Annu Rev Med, 60, 167, 10.1146/annurev.med.59.053006.104707

Mitchell, 2008, Circulating microRNAs as stable blood-based markers for cancer detection, Proc Natl Acad Sci U S A, 105, 10513, 10.1073/pnas.0804549105

Chen, 2008, Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases, Cell Res, 18, 997, 10.1038/cr.2008.282

Zhou, 2011, Plasma microRNA panel to diagnose hepatitis B virus-related hepatocellular carcinoma, J Clin Oncol, 29, 4781, 10.1200/JCO.2011.38.2697

Foss, 2011, miR-1254 and miR-574-5p: serum-based microRNA biomarkers for early-stage non-small cell lung cancer, J Thorac Oncol, 6, 482, 10.1097/JTO.0b013e318208c785

Ng, 2009, Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening, Gut, 58, 1375, 10.1136/gut.2008.167817

Hausler, 2010, Whole blood-derived miRNA profiles as potential new tools for ovarian cancer screening, Br J Cancer, 103, 693, 10.1038/sj.bjc.6605833

Chen, 2012, A panel of five circulating microRNAs as potential biomarkers for prostate cancer, Prostate, 72, 1443, 10.1002/pros.22495

Meng, 2006, Involvement of human micro-RNA in growth and response to chemotherapy in human cholangiocarcinoma cell lines, Gastroenterology, 130, 2113, 10.1053/j.gastro.2006.02.057

Selaru, 2009, MicroRNA-21 is overexpressed in human cholangiocarcinoma and regulates programmed cell death 4 and tissue inhibitor of metalloproteinase 3, Hepatology, 49, 1595, 10.1002/hep.22838

Chusorn, 2013, Overexpression of microRNA-21 regulating PDCD4 during tumorigenesis of liver fluke-associated cholangiocarcinoma contributes to tumor growth and metastasis, Tumour Biol, 34, 1579, 10.1007/s13277-013-0688-0

Chen, 2009, The role of microRNA expression pattern in human intrahepatic cholangiocarcinoma, J Hepatol, 50, 358, 10.1016/j.jhep.2008.09.015

Meng, 2008, Epigenetic regulation of microRNA-370 by interleukin-6 in malignant human cholangiocytes, Oncogene, 27, 378, 10.1038/sj.onc.1210648

Braconi, 2010, MicroRNA-dependent regulation of DNA methyltransferase-1 and tumor suppressor gene expression by interleukin-6 in human malignant cholangiocytes, Hepatology, 51, 881

Zhang, 2012, MicroRNA-26a promotes cholangiocarcinoma growth by activating beta-catenin, Gastroenterology, 143, 246, 10.1053/j.gastro.2012.03.045

Dechakhamphu, 2010, Accumulation of miscoding etheno-DNA adducts and highly expressed DNA repair during liver fluke-induced cholangiocarcinogenesis in hamsters, Mutat Res, 691, 9, 10.1016/j.mrfmmm.2010.06.003

Ikenaga, 2010, MicroRNA-203 expression as a new prognostic marker of pancreatic adenocarcinoma, Ann Surg Oncol, 17, 3120, 10.1245/s10434-010-1188-8

Takeshita, 2013, Serum microRNA expression profile: miR-1246 as a novel diagnostic and prognostic biomarker for oesophageal squamous cell carcinoma, Br J Cancer, 108, 644, 10.1038/bjc.2013.8

Zhao, 2013, Diagnostic and biological significance of microRNA-192 in pancreatic ductal adenocarcinoma, Oncol Rep, 30, 276, 10.3892/or.2013.2420

Matsumoto, 2013, Circulating p53-responsive microRNAs are predictive indicators of heart failure after acute myocardial infarction, Circ Res, 113, 322, 10.1161/CIRCRESAHA.113.301209

Starkey Lewis, 2011, Circulating microRNAs as potential markers of human drug-induced liver injury, Hepatology, 54, 1767, 10.1002/hep.24538

Liu, 2012, Genome-wide microRNA profiles identify miR-378 as a serum biomarker for early detection of gastric cancer, Cancer Lett, 316, 196, 10.1016/j.canlet.2011.10.034

Tanaka, 2009, Down-regulation of miR-92 in human plasma is a novel marker for acute leukemia patients, PLoS ONE, 4, e5532, 10.1371/journal.pone.0005532

Yongvanit, 2012, Oxidative and nitrative DNA damage: key events in opisthorchiasis-induced carcinogenesis, Parasitol Int, 61, 130, 10.1016/j.parint.2011.06.011

Sripa, 2012, The tumorigenic liver fluke Opisthorchis viverrini-multiple pathways to cancer, Trends Parasitol, 28, 395, 10.1016/j.pt.2012.07.006

Jin, 2011, MicroRNA-192 and -215 are upregulated in human gastric cancer in vivo and suppress ALCAM expression in vitro, Oncogene, 30, 1577, 10.1038/onc.2010.534

Luzna, 2011, Changes of microRNAs-192, 196a and 203 correlate with Barrett's esophagus diagnosis and its progression compared to normal healthy individuals, Diagn Pathol, 6, 114, 10.1186/1746-1596-6-114

Chung, 2010, miR-192 mediates TGF-beta/Smad3-driven renal fibrosis, J Am Soc Nephrol, 21, 1317, 10.1681/ASN.2010020134

Hasebe, 2001, Highly proliferative fibroblasts forming fibrotic focus govern metastasis of invasive ductal carcinoma of the breast, Mod Pathol, 14, 325, 10.1038/modpathol.3880310